These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen. Hero M, Wickman S, Hanhijärvi R, Siimes MA, Dunkel L. J Pediatr; 2005 Feb; 146(2):245-52. PubMed ID: 15689918 [Abstract] [Full Text] [Related]
3. Treatment of delayed male puberty: efficacy of aromatase inhibition. Dunkel L, Wickman S. J Pediatr Endocrinol Metab; 2001 Feb; 14 Suppl 6():1541-6. PubMed ID: 11837512 [Abstract] [Full Text] [Related]
4. Novel treatment of short stature with aromatase inhibitors. Dunkel L, Wickman S. J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):345-56. PubMed ID: 14623531 [Abstract] [Full Text] [Related]
6. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial. Wickman S, Sipilä I, Ankarberg-Lindgren C, Norjavaara E, Dunkel L. Lancet; 2001 Jun 02; 357(9270):1743-8. PubMed ID: 11403810 [Abstract] [Full Text] [Related]
7. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. Hero M, Norjavaara E, Dunkel L. J Clin Endocrinol Metab; 2005 Dec 02; 90(12):6396-402. PubMed ID: 16189252 [Abstract] [Full Text] [Related]
9. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty. Hero M, Toiviainen-Salo S, Wickman S, Mäkitie O, Dunkel L. J Bone Miner Res; 2010 Jul 02; 25(7):1536-43. PubMed ID: 20200972 [Abstract] [Full Text] [Related]
10. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature. Salehpour S, Alipour P, Razzaghy-Azar M, Ardeshirpour L, Shamshiri A, Monfared MF, Gharib A. Horm Res Paediatr; 2010 Jul 02; 74(6):428-35. PubMed ID: 20628237 [Abstract] [Full Text] [Related]
13. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature. Hero M, Mäkitie O, Kröger H, Nousiainen E, Toiviainen-Salo S, Dunkel L. Horm Res; 2009 Jul 02; 71(5):290-7. PubMed ID: 19339794 [Abstract] [Full Text] [Related]
14. Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. Bertelloni S, Baroncelli GI, Battini R, Perri G, Saggese G. J Bone Miner Res; 1995 Oct 02; 10(10):1488-95. PubMed ID: 8686504 [Abstract] [Full Text] [Related]
15. Progressive reduction of relative height in childhood predicts adult stature below target height in boys with constitutional delay of growth and puberty. Wehkalampi K, Vangonen K, Laine T, Dunkel L. Horm Res; 2007 Oct 02; 68(2):99-104. PubMed ID: 17377395 [Abstract] [Full Text] [Related]
16. Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone. Kohva E, Varimo T, Huopio H, Tenhola S, Voutilainen R, Toppari J, Miettinen PJ, Vaaralahti K, Viinamäki J, Backman JT, Hero M, Raivio T. Hum Reprod; 2020 Feb 29; 35(2):257-264. PubMed ID: 31958337 [Abstract] [Full Text] [Related]
18. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. Mauras N, Gonzalez de Pijem L, Hsiang HY, Desrosiers P, Rapaport R, Schwartz ID, Klein KO, Singh RJ, Miyamoto A, Bishop K. J Clin Endocrinol Metab; 2008 Mar 29; 93(3):823-31. PubMed ID: 18165285 [Abstract] [Full Text] [Related]
19. Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome. Wikström AM, Bay K, Hero M, Andersson AM, Dunkel L. J Clin Endocrinol Metab; 2006 Nov 29; 91(11):4705-8. PubMed ID: 16926256 [Abstract] [Full Text] [Related]